1 Antithrombotische und thrombolytische Behandlung: Internationale EBM-Guidelines, kommentiert von Schweizer Experten. The 7th ACCP Conference on Antithrombotic and Thrombolytic therapy. Schweiz Med Forum. 2005;5(Suppl.27):1–48S.
2 Traitement antithrombotique et thrombolytique: Commentaire des experts suisses concernant les «EBM-guidelines» internationales. 7th ACCP Conference on Antithrombotic and Thrombolytic therapy. Forum Med Suisse 2005;5(Suppl.28):1–48S.
3 Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease - CHEST Guideline and Expert Panel Report.
Chest. 2016;149(2):315–352.
4 Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest. 2006;129(1):174–181.
5 Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011;
64(4):401-406.
6 Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;
66(7):719–725.
7 Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation - determinants of a recommendation’s direction and strength. J Clin Epidemiol. 2013;66(7):726–735.
8 Wuillemin WA, Spirk D, Baumgartner I, Lüscher TF. Die neuen Empfehlungen des American College of Chest Physicians (ACCP) über antithrombotische Behandlung. Schweiz Med Forum. 2013;13(33):616–617.
9 Wuillemin WA, Spirk D, Baumgartner I, Lüscher TF. Nouvelles recommandations de l’American College of Chest Physicians (ACCP) sur les traitements antithrombotiques. Forum Med Suisse. 2013;13(33):616–617.